Feedmix Trim/Sul 80/420 premix voor gemedicineerd voer voor varkens Holandia - niderlandzki - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

feedmix trim/sul 80/420 premix voor gemedicineerd voer voor varkens

aesculaap b.v. - sulfadiazine natrium; sulfadiazine; trimethoprim - premix voor gemedicineerd voer - sulfadiazine natrium 84 mg/g; sulfadiazine 77,1 mg/g; trimethoprim 16 mg/g, - sulfadiazine and trimethoprim, incl. derivatives - varkens

Zilversulfadiazine crème Sinclair, créme 1% Holandia - niderlandzki - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

zilversulfadiazine crème sinclair, créme 1%

sinclair pharmaceuticals ltd unit 4, godalming business centre, woolsack way gu7 1xw godalming (verenigd koninkrijk) - zilversulfadiazine - crème - cetylalcohol ; glycerolmonostearaat 40-55 (e 471) ; paraffine, vloeibaar (e905) ; polysorbaat 60 (e 435) ; polysorbaat 80 (e 433) ; propyleenglycol (e 1520) ; water, gezuiverd, - silver sulfadiazine

EQUISUL-SDT- sulfadiazine and trimethoprim suspension Stany Zjednoczone - angielski - NLM (National Library of Medicine)

equisul-sdt- sulfadiazine and trimethoprim suspension

aurora pharmaceutical, inc. - sulfadiazine (unii: 0n7609k889) (sulfadiazine - unii:0n7609k889), trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - sulfadiazine 333 mg in 1 ml - equisul-sdt is contraindicated in horses with a known allergy to sulfadiazine, sulfonamide class antimicrobials, or trimethoprim.

THERMAZENE SILVER SULFADIAZINE- silver sulfadiazine cream Stany Zjednoczone - angielski - NLM (National Library of Medicine)

thermazene silver sulfadiazine- silver sulfadiazine cream

preferred pharmaceuticals, inc. - silver sulfadiazine (unii: w46jy43ejr) (silver cation - unii:57n7b0k90a) - silver sulfadiazine 10 mg in 1 g -      silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.      silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.      geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater s

SILVER SULFADIAZINE cream Stany Zjednoczone - angielski - NLM (National Library of Medicine)

silver sulfadiazine cream

h.j. harkins company, inc. - silver sulfadiazine (unii: w46jy43ejr) (silver sulfadiazine - unii:w46jy43ejr) - silver sulfadiazine 10 g in 1000 g - silver sulfadiazine cream is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns. silver sulfadiazine cream is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation. because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.

SILVER SULFADIAZINE cream Stany Zjednoczone - angielski - NLM (National Library of Medicine)

silver sulfadiazine cream

physicians total care, inc. - silver sulfadiazine (unii: w46jy43ejr) (silver sulfadiazine - unii:w46jy43ejr) - silver sulfadiazine 10 mg in 1 g - silver sulfadiazine cream is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns. silver sulfadiazine cream is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation. because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.

SILVER SULFADIAZINE cream Stany Zjednoczone - angielski - NLM (National Library of Medicine)

silver sulfadiazine cream

liberty pharmaceuticals, inc. - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - silver sulfadiazine 10 mg in 1 g - silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns. silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life. geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of

SILVER SULFADIAZINE cream Stany Zjednoczone - angielski - NLM (National Library of Medicine)

silver sulfadiazine cream

remedyrepack inc. - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - silver sulfadiazine 10 mg in 1 g -      silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.      silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.      geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients,

SILVER SULFADIAZINE cream Stany Zjednoczone - angielski - NLM (National Library of Medicine)

silver sulfadiazine cream

nucare pharmaceuticals,inc. - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - silver sulfadiazine 10 mg in 1 g - silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns. silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life. geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater se